# OnCo record iksuda-therapeutics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/iksuda-therapeutics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "iksuda-therapeutics" ;
  schema:name "Iksuda Therapeutics"@en ;
  schema:description "Iksuda Therapeutics, based in Newcastle, designs antibody-drug conjugates, antibodies that release a cancer-killing drug only once inside the tumour. Its HER2-targeting medicine is in early human trials, with encouraging results in oesophageal cancer."@en ;
  schema:url <https://onco.cc/companies/iksuda-therapeutics/>, <https://www.iksuda.com/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://www.iksuda.com/>, <https://www.iksuda.com/news-views/iksuda-therapeutics-closes-47-million-financing-round/>, <https://www.iksuda.com/news-views/> ;
  schema:addressCountry "GB" ;
  onco:cancers <https://onco.cc/cancers/esophageal/> ;
  onco:sections <https://onco.cc/fronts/adcs/> ;
  onco:technologies <https://onco.cc/technologies/adc/> ;
  onco:targets <https://onco.cc/targets/her2/>, <https://onco.cc/targets/cd19/> .